Additionally, cats and dogs treated with repeated local injections of engineered histo-incompatible cells secreting high levels of human interleukin-2 (hIL-2) to the tumor site relapse less frequently and survive longer than control animals treated by surgery and radiotherapy alone [12]. Here, IL2 is linked to neoplasm.